The role of fibroblast – Cardiomyocyte interaction for atrial dysfunction in HFpEF and hypertensive heart disease-Reference-Cited by-同舟云学术

The role of fibroblast – Cardiomyocyte interaction for atrial dysfunction in HFpEF and hypertensive heart disease

Published:2019-06 Issue: Volume:131 Page:53-65
ISSN:0022-2828
Container-title:Journal of Molecular and Cellular Cardiology
language:en
Short-container-title:Journal of Molecular and Cellular Cardiology

Author:

Bode David^ORCID,Lindner Diana,Schwarzl Michael,Westermann Dirk,Deissler Peter,Primessnig Uwe,Hegemann Niklas,Blatter Lothar A.,van Linthout Sophie,Tschöpe Carsten,Schoenrath Felix,Soltani Sajjad,Stamm Christof,Duesterhoeft Volker,Rolim Natale,Wisløff Ulrik,Knosalla Christoph,Falk Volkmar,Pieske Burkert M.,Heinzel Frank R.,Hohendanner Felix

Funder

German Centre for Cardiovascular Research

German Ministry of Education and Research

Charité –Universitätsmedizin Berlin and the Berlin Institute of Health

National Institute of Health

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Molecular Biology

Reference38 articles.

1. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

2. Trends in prevalence and outcome of heart failure with preserved ejection fraction;Owan;N. Engl. J. Med.,2006